# Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®

> **NCT00486252** · — · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 996 (actual)

## Conditions studied

- Glaucoma,Open-Angle
- Ocular Hypertension

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT00486252
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 996 (ACTUAL)
- **Last updated:** 2021-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486252, "Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00486252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*